ArticleJournal for immunotherapy of cancer2022

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.

Angelika Martina Starzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.